|1.||WO||WO/2013/180587 - Pressure tank||05.12.2013||
|PCT/PL2012/050017||ELPIGAZ SP. Z O.O.||JARZYŃSKI, Grzegorz|
Subject of the invention is a pressure tank, especially extended and toroidal, with different lengths in X, Y, Z axes, containing shells connected with more than one connecting coupler, equipped with connector pipes for tank fittings, brackets for tank and cover fixing, cover of tank fittings, inner shells, inner jackets, partitions, characterized in that the outer, upper shell (1) with outer, lower shell (2) create outer tank shell, having rectangular cross-sections with rounded corners, whereas inner jackets (6A, 6B) are connected with inner shells (4A, 4B, 5A, 5B) and/or outer shells (1, 2), beneficially inner shells are connected with middle tubes (7A, 7B, 7N), creating central couplers (L1, L2) of the tank, beneficially separated by partition (10), and connector pipes of tank fittings (9) are welded to tank walls in this way that the thickness of outer wall of connector pipe is between 0,4 to 1,8 of the thickness of tank elements.
|2.||WO||WO/2013/180588 - METHOD OF APPLYING A PROTECTIVE CLADDING, PARTICULARLY TO GAS-TIGHT MEMBRANES OF ENERGY BOILERS||05.12.2013||
||PCT/PL2013/000070||PLASMA SYSTEM S.A.||BOREK, Aleksander|
A method of applying a protective cladding, particularly to gas-tight membranes of energy boilers involves coupling of two gas-tight membranes (2) together, and then soaking a pair of gas-tight membranes (2) coupled together at 300°C to 800°C, favorably at around 700°C; afterwards, the membrane (2) surface where a cladding (1) is to be applied is cleaned, a pair of gas-tight membranes (2) coupled together is mounted on a positioner and then preheated up to 80°C to 600°C, favorably to around 300°C-450°C, and then the cleaned and preheated surface of a pair of gas- tight membranes (2) coupled together is covered with a protective cladding (1), wherein a protective cladding is applied at a thickness of 0.1 mm to 3.00 mm, favorably around 0.6 mm, and then the entire pair of gas-tight membranes (2) coupled together with a cladding (2) is finally soaked at 300°C to 800°C, favorably at around 700°C, and the set temperature is maintained for 10 minutes to 600 minutes, favorably for 15 minutes to 30 minutes, and finally, gas-tight membranes (2) with a cladding are uncoupled.
|3.||WO||WO/2013/180585 - NANOPRODUCT COMPRISING LACTOBACILLUS REUTERI DAN080 USEFUL IN PROPHYLAXIS AND MEDICINE, BOTH HUMAN AND VETERINARY AND MEDICAL USE OF THE SAME||05.12.2013||
|PCT/PL2012/000039||KRUSZEWSKA, Danuta||KRUSZEWSKA, Danuta|
The invention relates to a nanoproduct useful in prophylaxis and medicine, both human and veterinary as well as to a medical use of the same. The invention discloses Lactobacillus reuteri DAN080 strain with deposit number DSM 15693 for use in medicine. The various forms of preparations comprising the Lactobacillus reuteri DAN080 strain with deposit number DSM 15693 are disclosed for use in medicine as therapeutic and prophylactic agent, especially as an antimicrobial agent, in prophylaxis and treatment of medical conditions developing as a result of infections caused by bacteria, fungi, and other pathogens of the gastrointestinal tract, body surface, and other systems, such as urogenital system, respiratory system, in vertebrates or as a therapeutic and/or prophylactic agent for the treatment and prevention of development of gout (podagra) and/or for increasing the activity of lysozyme in an organism of vertebrate, especially human, other mammal or bird. Also the medical instruments such as catheters and hygienic articles including Lactobacillus reuteri DAN080 strain with deposit number DSM 15693 culture products are disclosed.
|4.||WO||WO/2013/180586 - CONTAINER FOR TRANSPORT OF PRODUCTS, ESPECIALLY IN THE FORM OF COILS||05.12.2013||
|PCT/PL2012/000093||LAUDE. PL SPÓŁKA Z.O.O.||WITCZAK, Marcin|
The present invention is a container for the transport of products, particularly in the form of coils, comprising a floor (1), two side walls (2), a front wall (3), two doors (4) and a removable rigid roof (5) with a fastening mechanism. The floor (1) is equipped with movable supports with a fastening mechanism, grouped in at least one pair, located along its longer axis of symmetry, opposite to each other. In the closed position, the supports form a horizontal plane with the floor (1), while in the open position, they form a trough. The pivoting support, forming part of one pair consists of a flap (6) connected to the flap support (7) or a wide flap (8) connected to the wide flap support (9) or (10). The flap (6) and the wide flap (8) are movably connected with the floor (1) by means of hinges (11) located on one of the edges, whereas the flap (6) and the wide flap (8) are connected movably by the other edge by means of hinges (11) with the flap support (7) or the wide flap support (9 and 10). The floor (1) is equipped with two grooves (12), parallel to each other, and running through the whole length of it situated on both sides of the long axis of symmetry of the floor (1) and located below the flap supports (7) or the wide flap supports (9 and 10) lying horizontally.
|5.||WO||WO/2013/176558 - FLEXIBLE ROADWAY SUPPORT FRAME||28.11.2013||
|PCT/PL2012/000074||ZAKŁADY METALOWE "KOZAMEX" KOZA ZDZISŁAW||KOZA, Zdzisław|
The flexible roadway support frame Fig. 1 equipped with roof-bar arches(l) and sidewall arches (2) connected with each other by means of double-yoke stirrups with overlap (3, 4, 5) characterized in that each arch has a cut-out in the flanges located at the ends of those arches Fig 2.
|6.||WO||WO/2013/176559 - HYDRAULIC OPERATING DEVICE||28.11.2013||
|PCT/PL2013/000065||SIGMA S.A.||CHMIELEWSKI, Jacek|
The device consists of an actuator (1) supplied with hydraulic fluid through the valve block (2), wherein the actuator (1) is provided with a measuring unit (3) and two pressure sensors, the first sensor (9a) is mounted under the piston, and a second sensor (9b) is mounted above the piston. The first sensor (9a), the second sensor (9b), the measuring unit (3) and the valve block (2) are connected with the automatic control system (4) equipped with a transceiver (6). These elements are powered by the generator (10) via the battery bank (11), wherein the generator is powered by hydraulic fluid that drives the actuator (1). All elements of the device (8) are connected to the actuator's cylinder (1).
|7.||WO||WO/2013/176561 - WEIGHING CHAMBER OF AN ANALYTICAL BALANCE||28.11.2013||
|PCT/PL2013/000068||LEWANDOWSKI, Witold||LEWANDOWSKI, Witold|
A weighing chamber in a shape of a transparent cuboid with sliding panels (1, 2, 3, 4, 5) assembled on structural guides (8) that are fastened using at least a single adjustable lock (13) blocking at least one panel in a way that their releasing enables sliding and disassembling the other panels. The fastening lock forms a profiled element, preferably an angle bar shaped component assembled in a detachable manner to the horizontal structural beam (8). The chamber comprises two vertical columns (6, 7) assembled at the back corners of the chamber's interior which support the chamber structure (8) comprising a horizontal beam for assembling the fastening lock and guides for holding and sliding the top and side panels using grips (9,10,11).
|8.||WO||WO/2013/176560 - AN INSULIN ANALOGUE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, PHARMACEUTICAL COMPOSITION WITH PROLONGED THERAPEUTIC EFFECT, USE OF THE INSULIN ANALOGUE, DOSAGE METHOD AND METHOD OF TREATMENT OF DIABETES||28.11.2013||
|PCT/PL2013/000066||INSTYTUT BIOTECHNOLOGII I ANTYBIOTYKÓW||BOROWICZ, Piotr|
The invention relates to an insulin analogue or its pharmaceutically acceptable salt, pharmaceutical composition with prolonged therapeutic effect, application of the insulin analogue, dosage method and method of treatment of diabetes. In more detail, the solution pertains to compounds being stable insulin analogues which are pharmaceutically active and characterised by a prolonged, flat, truly peakless course of glucose concentration vs. time during repeated administration and which do not show strong 24 hours fluctuations of glucose concentration, or the so-called "sawteeth effect", during this time. Results of studies of compounds included in the scope of this application indicate an improvement in the effects of diabetes treatment by avoiding the hitherto occurring adverse influence of changes in glucose concentration throughout the entire day on a patient's organism, e.g. night hypoglycaemias, because truly peakless, long-acting insulin should reproduce correct endogenous insulin secretion in the therapy, as is provided by a healthy pancreas at a proper and constant 24 hours level.
|9.||WO||WO/2013/172723 - POLYESTER COMPOSITION OF REDUCED FLAMMABILITY||21.11.2013||
|PCT/PL2012/000055||INSTYTUT INŻYNIERII MATERIAŁOW POLIMEROWYCH I BARWNIKÓW||KICKO-WALCZAK, Ewa|
The present invention refers to a polyester composition of reduced flammability being a mixture of an unsaturated free radical copolymerizable polyester and a cross-linking monomer, a flammability reducing modifier and auxiliary agents, wherein as a flammability reducing modifier it contains a halogen-free multi-component synergy-based mixture with a melamine salt in the form of melamine polyphosphate and/or melamine cyanurate and/or melamine borate and/or melamine oxalate in the quantity of 5.0-30.0 parts by weight per 100 parts by weight of an unsaturated polyester resin and a nanofiller in the form of precipitated synthetic silica and/or montmorillonite and/or expandable graphite in the quantity of 5.0-40.0 parts by weight per 100 parts by weight of unsaturated polyester resin.
|10.||WO||WO/2013/172724 - METHOD FOR TREATING OBESITY AND OVERWEIGHT AND GASTRO-OESOPHAGEAL REFLUX DISEASE||21.11.2013||
|PCT/PL2013/000063||KOWALCZYK, Zbigniew||KOWALCZYK, Zbigniew|
The present invention relates to the method for treating obesity and overweight and gastro-oesophageal reflux disease (GERD). According to the invention the method for treating obesity and overweight and gastro-oesophageal reflux disease lies in the fact that the stem and regenerative cells extracted from adipose tissue (ADRC - Adipose Derived Regenerative Cells) are injected into the submucosa tissue or muscle near the gastric cardia and fundus. The isolated ADRC cells are given via endoscopy or surgical procedures, open or laparoscopic. The isolated ADRC cells are enriched with fat graft in the amount of at least 5 ml and not more than 25 ml. The method is complementary to other bariatric procedures reducing the size of the stomach - such as adjustable gastric band, gastric sleeve partial resection,or filling the stomach - as intragastric implants, or affecting the motility or satiety induction by electrical stimulation (neurostimulators). It is preferred when the method is applied while other surgical procedures to obese or overwieght patients. In the treatment of gastro-oesophageal reflux disease the stem and regenerative cells isolated from its own adipose tissue (ADRC - Adipose Derived Regenerative Cells) are injected into the submucosa or muscle tissue around gastric cardia.